Compounds > bosentan anhydrous
Page last updated: 2024-08-26

bosentan anhydrous and Intermittent Claudication

bosentan anhydrous has been researched along with Intermittent Claudication in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acin, F; Bleda, S; De Haro, J; Gonzalez-Hidalgo, C; Michel, I1
Acin, F; Bleda, S; De Haro, J; Esparza, L; Varela, C1

Trials

2 trial(s) available for bosentan anhydrous and Intermittent Claudication

ArticleYear
Long-Term Effects of Bosentan on Cardiovascular Events in Hispanic Patients with Intermittent Claudication: Four-Year Follow-up of the CLAU Trial : The CLAU Randomized Trial Long-Term Outcome.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2019, Volume: 19, Issue:2

    Topics: Antihypertensive Agents; Atherosclerosis; Bosentan; Follow-Up Studies; Hispanic or Latino; Humans; Intermittent Claudication; Male; Middle Aged; Peripheral Arterial Disease; Treatment Outcome

2019
Effect of Bosentan on Claudication Distance and Endothelium-Dependent Vasodilation in Hispanic Patients With Peripheral Arterial Disease.
    The American journal of cardiology, 2016, Jan-15, Volume: 117, Issue:2

    Topics: Ankle Brachial Index; Bosentan; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Endothelium, Vascular; Follow-Up Studies; Humans; Intermittent Claudication; Male; Middle Aged; Pilot Projects; Sulfonamides; Treatment Outcome; Vasodilation

2016